The study found that a single low-dose injection of esketamine given just after childbirth could reduce the risk of postpartum depression in new mothers who experienced prenatal depression.

Since respiratory viral infections are known to increase asthma risk in young children, researchers of a new study investigated if contracting the SARS-COV-2 virus could bring in a similar outcome, and determined no association exists between the two.